According to the latest data from the Hong Kong Stock Exchange, on May 15, Norges Bank purchased an additional 254,500 shares of Pharmaron (03759) at a price of HK$18.707 per share, with a total transaction value of approximately HK$4.7609 million. Following this acquisition, Norges Bank's total shareholding in the company has increased to about 24.9317 million shares, representing a 7.07% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments